Impact of safety warnings for fluoroquinolones on prescribing behaviour. Results of a cohort study with outpatient routine data.

Georgi, Ulrike; Tesch, Falko; Schmitt, Jochen; de With, Katja

Georgi, Ulrike; Tesch, Falko; Schmitt, Jochen; de With, Katja.

Afiliación

Georgi U; Pharmacy Service of Clinical Center, Flemmingstrasse 2, 09116, Chemnitz, Germany. u.georgi@skc.de.
Tesch F; Center for Evidence-Based Healthcare, University Hospital and Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany. u.georgi@skc.de.
Schmitt J; Center for Evidence-Based Healthcare, University Hospital and Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany.
de With K; Center for Evidence-Based Healthcare, University Hospital and Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany.

Infection ; 49(3): 447-455, 2021 Jun.

Article en En | MEDLINE | ID: mdl-33258075

Asunto(s)

Fluoroquinolonas; Pacientes Ambulatorios; Antibacterianos/efectos adversos; Estudios de Cohortes; Fluoroquinolonas/efectos adversos; Humanos; Levofloxacino; Moxifloxacino

Palabras clave

Antibiotic use; Cohort studies; Fluoroquinolones; Patient safety; Pharmacovigilance; Practice patterns

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pacientes Ambulatorios / Fluoroquinolonas Tipo de estudio: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Infection Año: 2021 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google